Literature DB >> 4611433

Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 7: Clinical investigation. Efficacy and safety of loperamide in patients with severe chronic diarrhea.

H Verhaegen, J De Cree, V Schuermans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4611433

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN： 0004-4172


× No keyword cloud information.
  5 in total

1.  Effect of loperamide on fecal output and composition in well-established ileostomy and ileorectal anastomosis.

Authors:  G N Tytgat; K Huibregtse; J Dagevos; A van den Ende
Journal:  Am J Dig Dis       Date:  1977-08

2.  Loperamide, diphenoxylate, and codeine phosphate in chronic diarrhoea.

Authors:  C D Shee; R E Pounder
Journal:  Br Med J       Date:  1980-02-23

3.  Double-blind placebo-controlled study of loperamide (Imodium) in chronic diarrhoea caused by ileocolic disease or resection.

Authors:  P Mainguet; R Fiasse
Journal:  Gut       Date:  1977-07       Impact factor: 23.059

Review 4.  Loperamide: a review of its pharmacological properties and therapeutic efficacy in diarrhoea.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-01       Impact factor: 9.546

5.  Loperamide has antisecretory activity in the human jejunum in vivo.

Authors:  S Hughes; N B Higgs; L A Turnberg
Journal:  Gut       Date:  1984-09       Impact factor: 23.059
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.